LBF20307PG04: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
|LipidMaps=LMFA03010132 | |LipidMaps=LMFA03010132 | ||
|SysName=7- [ 2- (3 (S) ,7-Dihydroxy-1 (E) -octenyl) -5-oxo-1-cyclopenten-1-yl ] -5 (Z) -heptenoic acid / 15 (S) ,19-Dihydroxy-9-oxo-5-cis-8 (12) ,13-trans-prostatrienoic acid | |SysName=7- [ 2- (3 (S) ,7-Dihydroxy-1 (E) -octenyl) -5-oxo-1-cyclopenten-1-yl ] -5 (Z) -heptenoic acid / 15 (S) ,19-Dihydroxy-9-oxo-5-cis-8 (12) ,13-trans-prostatrienoic acid | ||
|Common Name=&&19-HYDROXY-PROSTAGLANDIN B_2&&7- [ 2- (3 (S) ,7-Dihydroxy-1 (E) -octenyl) -5-oxo-1-cyclopenten-1-yl ] -5 (Z) -heptenoic acid | |Common Name=&&19-HYDROXY-PROSTAGLANDIN B_2&&7- [ 2- (3 (S) ,7-Dihydroxy-1 (E) -octenyl) -5-oxo-1-cyclopenten-1-yl ] -5 (Z) -heptenoic acid&&15 (S) ,19-Dihydroxy-9-oxo-5-cis-8 (12) ,13-trans-prostatrienoic acid&& | ||
|Solubility=ETHANOL [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]] | |Solubility=ETHANOL [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]] | ||
|UV Spectra=<FONT FACE="Symbol">l</FONT> <SUP><FONT SIZE=-1>E</FONT></SUP><SUP><FONT SIZE=-1>t</FONT></SUP><SUP><FONT SIZE=-1>O</FONT></SUP><SUP><FONT SIZE=-1>H</FONT></SUP><SUB><FONT SIZE=-1>m</FONT></SUB><SUB><FONT SIZE=-1>a</FONT></SUB><SUB><FONT SIZE=-1>x</FONT></SUB> = 278 nm(<FONT FACE="Symbol">e</FONT> ˜20,000) [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]] | |UV Spectra=<FONT FACE="Symbol">l</FONT> <SUP><FONT SIZE=-1>E</FONT></SUP><SUP><FONT SIZE=-1>t</FONT></SUP><SUP><FONT SIZE=-1>O</FONT></SUP><SUP><FONT SIZE=-1>H</FONT></SUP><SUB><FONT SIZE=-1>m</FONT></SUB><SUB><FONT SIZE=-1>a</FONT></SUB><SUB><FONT SIZE=-1>x</FONT></SUB> = 278 nm(<FONT FACE="Symbol">e</FONT> ˜20,000) [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]] | ||
|IR Spectra= 5.92, 6.09, 6.26, 10.3<FONT FACE="Symbol">m</FONT>m [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]] | |IR Spectra= 5.92, 6.09, 6.26, 10.3<FONT FACE="Symbol">m</FONT>m [[Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257|{{RelationTable/GetFirstAuthor|Reference:Hamberg_M:Samuelsson_B:,J. Biol. Chem.,1966,241,257}}]] | ||
}} | }} | ||
Revision as of 00:02, 20 December 2008
| IDs and Links | |
|---|---|
| LipidBank | XPR1131 |
| LipidMaps | LMFA03010132 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20307PG04 |
| 19-HYDROXY-PROSTAGLANDIN B2 | |
|---|---|
| |
| Structural Information | |
| 7- [ 2- (3 (S) ,7-Dihydroxy-1 (E) -octenyl) -5-oxo-1-cyclopenten-1-yl ] -5 (Z) -heptenoic acid / 15 (S) ,19-Dihydroxy-9-oxo-5-cis-8 (12) ,13-trans-prostatrienoic acid | |
| |
| Formula | C20H30O5 |
| Exact Mass | 350.20932407 |
| Average Mass | 350.4492 |
| SMILES | O[C@H](CCC[C@H](C)O)C=CC(=C1CC=CCCCC(O)=O)CCC(=O)1 |
| Physicochemical Information | |
| ETHANOL HambergMet al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | l EtOHmax = 278 nm(e ˜20,000) HambergMet al. |
| IR Spectra | 5.92, 6.09, 6.26, 10.3mm HambergMet al. |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
